Dinucleotide prodrug

A technology of dinucleosides and precursor compounds, which can be applied to sugar derivatives, pharmaceutical formulations, organic active ingredients, etc., and can solve problems such as not meeting the Lipinski standard
CN110467646AInactive Publication Date: 2019-11-19BRIGHTGENE BIO MEDICAL TECH (SUZHOU) CO LTD
5 Cites 2 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
BRIGHTGENE BIO MEDICAL TECH (SUZHOU) CO LTD
Publication Date
2019-11-19
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention provides a dinucleotide prodrug being novel in structure, and further provides a preparation method of a dinucleotide prodrug, and an application of the dinucleotide prodrug to preparation of drugs for treating viral infection, particularly to drugs for treating hepatitis B virus (HBV) infection and HBV relevant liver diseases. The dinucleotide prodrug compound can notably improve the target properties in the liver, can improve the accumulation capacity in liver locations, can further effectively improve the drug effect and activity, can reduce the use dosage, and can further reduce the toxic and side effects. Experimentation on animals indicates that after being absorbed in bodies, the dinucleotide prodrug compound can be rapidly distributed in extravascular tissue from a central compartment, and can be concentrated massively in the liver, and low dosage of the dinucleotide prodrug compound can be observed in other tissue. The dinucleotide prodrug compound provided by the invention also has the advantages of being high in biological availability when being taken orally, good in stability in the stomach, and long in life in vivo.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a dinucleotide prodrug with novel structure. It also relates to the preparation method of the dinucleotide prodrug of the present invention, and its application in the preparation of medicines for treating viral infections, especially hepatitis B virus (HBV) infection and HBV-related liver diseases. Background technique

[0002] Hepatitis B is one of the diseases with the greatest social burden in our country. At present, about 100 million people in my country are hepatitis B virus carriers, accounting for about 8%-10% of the total population in my country, and there are about 20 million people with chronic hepatitis B (inflammatory lesions have appeared in the liver). It is estimated that there are 350 million chronic HBV carriers worldwide. According to the Centers for Disease Control, approximately 3 to 7 million people die each year from infection-related complications such as cirrhosis and hepatocellular carcinoma. A la...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More